SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-029295
Filing Date
2022-08-19
Accepted
2022-08-19 16:57:24
Documents
1
Period of Report
2022-08-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9450
  Complete submission text file 0000899243-22-029295.txt   11409
Mailing Address 700 CANAL STREET, 2ND FLOOR STAMFORD CT 06902
Business Address 700 CANAL STREET, 2ND FLOOR STAMFORD CT 06902 203-516-3730
M28 Capital Management LP (Reporting) CIK: 0001807489 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40703 | Film No.: 221181447

Mailing Address C/O SQZ BIOTECHNOLOGIES COMPANY 200 ARSENAL YARDS BOULEVARD, SUITE 210 WATERTOWN MA 02472
Business Address
Elia Marc (Reporting) CIK: 0001830496 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40703 | Film No.: 221181448

Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Adagio Therapeutics, Inc. (Issuer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)